UK based drug major GlaxoSmithKline began work for setting up a Rs 1000 crore pharmaceutical manufacturing unit in Karnataka, India. Karnataka Chief Minister Siddaramaiah laid the foundation stone in the presence of UK's Minister of State for Trade and Investment Francis Maude.
It will be fully operational in 2017 and will make more than 8 billion tablets and 1 billion capsules for the Indian market. The facility will be built on a 50-acre site in Vemgal, it said. The facility will also include a warehouse, employee welfare center and utilities to support the manufacturing and packing of medicines.
The Managing Director of company Annaswamy Vaidheesh said in a statement that GSK has been at the forefront of serving the healthcare needs of India for more than 90 years. H added "We fully support the Government in their efforts to increase access to affordable medicines to improve healthcare and we are very excited to begin work on what will become our largest manufacturing facility in India."
